Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome.

Rai PK, Craven L, Hoogewijs K, Russell OM, Lightowlers RN.

Essays Biochem. 2018 Jul 20;62(3):455-465. doi: 10.1042/EBC20170113. Print 2018 Jul 20. Review.

PMID:
29950320
2.

Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo.

Russell OM, Fruh I, Rai PK, Marcellin D, Doll T, Reeve A, Germain M, Bastien J, Rygiel KA, Cerino R, Sailer AW, Lako M, Taylor RW, Mueller M, Lightowlers RN, Turnbull DM, Helliwell SB.

Sci Rep. 2018 Jan 29;8(1):1799. doi: 10.1038/s41598-018-20064-2.

3.

Using the Electronic Health Record Data in Real Time and Predictive Analytics to Prevent Hospital-Acquired Postoperative/Surgical Site Infections.

Falen T, Noblin AM, Russell OL, Santiago N.

Health Care Manag (Frederick). 2018 Jan/Mar;37(1):58-63. doi: 10.1097/HCM.0000000000000196.

PMID:
29266086
4.

Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector.

Sari O, Boucle S, Cox BD, Ozturk T, Russell OO, Bassit L, Amblard F, Schinazi RF.

Eur J Med Chem. 2017 Sep 29;138:407-421. doi: 10.1016/j.ejmech.2017.06.062. Epub 2017 Jun 29.

PMID:
28688280
5.

Presence of Type I-F CRISPR/Cas systems is associated with antimicrobial susceptibility in Escherichia coli.

Aydin S, Personne Y, Newire E, Laverick R, Russell O, Roberts AP, Enne VI.

J Antimicrob Chemother. 2017 Aug 1;72(8):2213-2218. doi: 10.1093/jac/dkx137.

PMID:
28535195
6.

Characterization of β-d-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus.

Ehteshami M, Tao S, Zandi K, Hsiao HM, Jiang Y, Hammond E, Amblard F, Russell OO, Merits A, Schinazi RF.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02395-16. doi: 10.1128/AAC.02395-16. Print 2017 Apr.

7.

Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors.

Boucle S, Lu X, Bassit L, Ozturk T, Russell OO, Amblard F, Coats SJ, Schinazi RF.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):904-910. doi: 10.1016/j.bmcl.2017.01.010. Epub 2017 Jan 6.

8.

Applying the Airbrakes: Treating Mitochondrial Disease with Hypoxia.

Russell OM, Lightowlers RN, Turnbull DM.

Mol Cell. 2016 Apr 7;62(1):5-6. doi: 10.1016/j.molcel.2016.03.027.

9.

Potential compounds for the treatment of mitochondrial disease.

Rai PK, Russell OM, Lightowlers RN, Turnbull DM.

Br Med Bull. 2015;116:5-18. doi: 10.1093/bmb/ldv046. Epub 2015 Nov 20. Review.

PMID:
26590387
10.

Mitochondrial DNA disease-molecular insights and potential routes to a cure.

Russell O, Turnbull D.

Exp Cell Res. 2014 Jul 1;325(1):38-43. doi: 10.1016/j.yexcr.2014.03.012. Epub 2014 Mar 24. Review.

11.

The diagnosis and management of learning disability.

Russell O.

Practitioner. 2006 Oct;250(1687):39, 41-3. Review. No abstract available.

PMID:
17066889
12.

The mammalian amiloride-insensitive non-specific salt taste receptor is a vanilloid receptor-1 variant.

Lyall V, Heck GL, Vinnikova AK, Ghosh S, Phan TH, Alam RI, Russell OF, Malik SA, Bigbee JW, DeSimone JA.

J Physiol. 2004 Jul 1;558(Pt 1):147-59. Epub 2004 May 14.

13.

Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII.

Freedman J, Rand ML, Russell O, Davis C, Cheatley PL, Blanchette V, Garvey MB.

Transfusion. 2003 Nov;43(11):1508-13.

PMID:
14617307
14.

Modulation of rat chorda tympani NaCl responses and intracellular Na+ activity in polarized taste receptor cells by pH.

Lyall V, Alam RI, Phan TH, Russell OF, Malik SA, Heck GL, DeSimone JA.

J Gen Physiol. 2002 Dec;120(6):793-815.

15.
16.

How to meet a challenge.

Harris P, Russell O.

Health Serv J. 1992 Oct 8;102(5323):28-9. No abstract available.

PMID:
10122024
17.
18.

The community mental health nurse: a new professional role.

Hall V, Russell O.

J Adv Nurs. 1982 Jan;7(1):3-10.

PMID:
6917867
19.

Moral and legal aspects of euthanasia.

Russell OR.

Humanist. 1974 Jul-Aug;34(4):22-7. No abstract available.

PMID:
11661124
20.

Shock.

Russell OE.

Columbus Dent Soc Bull. 1971 Feb;30(2):5-6. No abstract available.

PMID:
5278593
21.

CYSTIC DISEASE OF THE RENAL MEDULLA.

KERLAN M, RUSSELL OQ.

J Tenn Med Assoc. 1963 Aug;56:330-2. No abstract available.

PMID:
14045557
22.

LD50 and minimal effective antimitotic dose of colchicine in various rodents.

FLEISCHMANN W, RUSSELL OQ, FLEISCHMANN SK.

Med Exp Int J Exp Med. 1962;6:101-4. No abstract available.

PMID:
13893509

Supplemental Content

Loading ...
Support Center